ArticleHeliyon2023

Ezetimibe inhibits triple-negative breast cancer proliferation and promotes cell cycle arrest by targeting the PDGFR/AKT pathway.

Qinyu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.